Fluidigm Corp (FLDM)-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Fluidigm Corp (FLDM) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8014317
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:51
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Fluidigm Corp (Fluidigm) formerly known as Mycometrix Corporation, is a biotechnology company which manufactures life-science tools and creates technologies based on microfluidics and mass cytometry. The company’s products systems include biomark HD system, access array system, C1 system, callisto system, EP1 system, polaris system, juno system, and helios. It also provides custom assays such as SNP type assays, maxplar antibodies, delta gene assays and access array assays. Fluidigm offers software, which include fluidigm cytobank analysis, singular analysis toolset, SNP genotyping analysis, real-time PCR analysis, and digital PCR analysis. The company’s C1 system supports mRNA sequencing, DNA sequencing, miRNA analysis and additional applications through the C1 open app IFC. It has operations in France, Canada, Singapore, China, Japan, Australia, the UK and Germany. Fluidigm is headquartered in South San Francisco, California, the US.

Fluidigm Corp (FLDM) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Fluidigm Corp, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
Fluidigm Corp, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7
Fluidigm Corp, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
Fluidigm Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 9
Fluidigm Corp, Medical Devices Deals, 2011 to YTD 2017 10
Fluidigm Corp, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 11
Fluidigm Corp, Pharmaceuticals & Healthcare, Deal Details 12
Partnerships 12
Fluidigm Enters Into Co-Marketing Agreement With Olink Bioscience For Protein Biomarkers 12
Fluidigm Enters Into Co-Development Agreement With DKMS For High Throughput HLA Typing System 14
Genome Institue of Singapore Partners With Fluidigm To Establish Single-Cell Genomics Research Center 15
DVS Sciences And Cytobank Enter Into Co-Development Agreement 16
Equity Offering 17
Fluidigm Raises USD30 Million in Public Offering of Shares 17
Fluidigm Completes Public Offering Of Common Stock For US$60 Million 18
Fluidigm Completes IPO Of Common Stock For US$86.3 Million 20
Debt Offering 22
Fluidigm Completes Public Offering Of Notes Due 2034 For US$201.3 Million 22
Fluidigm Corp – Key Competitors 24
Fluidigm Corp – Key Employees 25
Fluidigm Corp – Locations And Subsidiaries 26
Head Office 26
Other Locations & Subsidiaries 26
Recent Developments 27
Strategy And Business Planning 27
Aug 04, 2016: Fluidigm Introduces New High-Throughput Targeted NGS Library Preparation System 27
Jun 09, 2016: Fluidigm Announces New Customer Inspiration Center in Canada for Mass Cytometry 28
Financial Announcements 29
Nov 02, 2017: Fluidigm Announces Third Quarter Financial Results and Operational Progress 29
May 04, 2017: Fluidigm Announces First Quarter Financial Results 31
Feb 08, 2017: Fluidigm Announces Q4 And Full Year 2016 Financial Results 34
Jan 09, 2017: Fluidigm Announces Preliminary Revenue For The Fourth Quarter And Full Year 36
Nov 03, 2016: Fluidigm Announces Third Quarter Financial Results 37
Oct 12, 2016: Fluidigm Announces Preliminary Third Quarter 2016 Revenue 39
Aug 04, 2016: Fluidigm Announces Q2 2016 Financial Results 40
May 05, 2016: Fluidigm Announces First Quarter Financial Results 42
Feb 04, 2016: Fluidigm Announces Q4-Full Year 2015 Financial Results 44
Jan 12, 2016: Fluidigm Announces Preliminary Full Year and Fourth Quarter 2015 Revenue 45
Corporate Communications 46
Mar 27, 2017: Nicolas Barthelemy and Carlos Paya Join Fluidigm Board of Directors 46
Oct 19, 2016: Fluidigm Names S. Christopher Linthwaite as New Chief Executive Officer 47
Aug 04, 2016: Fluidigm Appoints New President and Chief Operating Officer 48
Legal and Regulatory 49
Aug 04, 2016: Fluidigm Receives ISO 13485 And ISO 9001 Certification 49
Product News 50
Dec 21, 2016: Fluidigm Introduces A New Medium-Cell High-Throughput Integrated Fluidic Circuit 50
Appendix 51
Methodology 51
About GlobalData 51
Contact Us 51
Disclaimer 51

List of Tables
Fluidigm Corp, Pharmaceuticals & Healthcare, Key Facts, 2016 2
Fluidigm Corp, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
Fluidigm Corp, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7
Fluidigm Corp, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
Fluidigm Corp, Deals By Therapy Area, 2011 to YTD 2017 9
Fluidigm Corp, Medical Devices Deals, 2011 to YTD 2017 10
Fluidigm Corp, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 11
Fluidigm Enters Into Co-Marketing Agreement With Olink Bioscience For Protein Biomarkers 12
Fluidigm Enters Into Co-Development Agreement With DKMS For High Throughput HLA Typing System 14
Genome Institue of Singapore Partners With Fluidigm To Establish Single-Cell Genomics Research Center 15
DVS Sciences And Cytobank Enter Into Co-Development Agreement 16
Fluidigm Raises USD30 Million in Public Offering of Shares 17
Fluidigm Completes Public Offering Of Common Stock For US$60 Million 18
Fluidigm Completes IPO Of Common Stock For US$86.3 Million 20
Fluidigm Completes Public Offering Of Notes Due 2034 For US$201.3 Million 22
Fluidigm Corp, Key Competitors 24
Fluidigm Corp, Key Employees 25
Fluidigm Corp, Other Locations 26
Fluidigm Corp, Subsidiaries 26

★海外企業調査レポート[Fluidigm Corp (FLDM)-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • First Hotel Company Ltd.:企業の戦略・SWOT・財務情報
    First Hotel Company Ltd. - Strategy, SWOT and Corporate Finance Report Summary First Hotel Company Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Gran Tierra Energy Inc. (GTE)-石油・ガス分野:企業M&A・提携分析
    Summary Gran Tierra Energy Inc. (Gran Tierra) is an independent energy company. It acquires, explores, and develops oil and gas fields. The company produces crude oil, natural gas, and oil equivalent resources from its fields. Gran Tierra has onshore oil and gas properties in Colombia; and also owns …
  • Sonova Holding AG:企業の戦略・SWOT・財務情報
    Sonova Holding AG - Strategy, SWOT and Corporate Finance Report Summary Sonova Holding AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Sagemcom SAS:企業の戦略的SWOT分析
    Sagemcom SAS - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Biohaven Pharmaceutical Holding Company Ltd (BHVN):製薬・医療:M&Aディール及び事業提携情報
    Summary Biohaven Pharmaceutical Holding Company Ltd (Biohaven), a subsidiary of Portage Biotech Inc, is a clinical-stage biopharmaceutical company that develops late-stage product candidates for neurological diseases. The company develops small molecule CGRP receptor antagonist platform that include …
  • Acceleron Pharma Inc (XLRN):企業の財務・戦略的SWOT分析
    Acceleron Pharma Inc (XLRN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Tufts Medical Center:製薬・医療:M&Aディール及び事業提携情報
    Summary Tufts Medical Center (TMC), formerly New England Medical Center Hospital Inc, a subsidiary of Tufts University School of Medicine, is an academic medical center that provides patient care services. The center offers treatments for brain tumor, breast cancer, cardiac arrhythmia, cardiomyopath …
  • Inogen Inc (INGN):企業の財務・戦略的SWOT分析
    Summary Inogen Inc (Inogen) is a medical device company that offers oxygen therapy technology solutions. The company offers products which include g2 portable oxygen concentrator system, g3 portable oxygen concentrator system, home oxygen concentrator and accessory items. Its products are used in bo …
  • Orica Ltd:企業の戦略・SWOT・財務分析
    Orica Ltd - Strategy, SWOT and Corporate Finance Report Summary Orica Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • Domainex Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Domainex Ltd (Domainex) is a drug discovery service company that offers drug discovery programmes against a wide range of drug targets. The company provides services such as molecular biology / cdh, protein expression, assays, fragment screening, virtual screening, computational chemistry, m …
  • Hibu Group Limited:戦略・SWOT・企業財務分析
    Hibu Group Limited - Strategy, SWOT and Corporate Finance Report Summary Hibu Group Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • CITIC Telecom International Holdings Ltd (1883):企業の財務・戦略的SWOT分析
    CITIC Telecom International Holdings Ltd (1883) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key st …
  • Warner Media LLC.:企業の戦略・SWOT・財務情報
    Warner Media LLC. - Strategy, SWOT and Corporate Finance Report Summary Warner Media LLC. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Zhejiang Geely Holding Group Co Ltd:企業のM&A・事業提携・投資動向
    Zhejiang Geely Holding Group Co Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Zhejiang Geely Holding Group Co Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on …
  • MedicPen AB (MPEN):医療機器:M&Aディール及び事業提携情報
    Summary MedicPen AB (MedicPen) is a drug development company that manufactures, develops, and markets patented products. The company’s products include Medimi Pro and Medimi Smart. It also provides Medimi – MedicPen’s system for medication assistance. MedicPen offers automatic filling units for home …
  • SpectraScience Inc (SCIE):企業の製品パイプライン分析2018
    Summary SpectraScience Inc (SpectraScience) is a medical device company, which undertakes the design, development, manufacture and marketing of light-based technology products. The company offers its proprietary WavSTAT Optical Biopsy System to diagnose tissue health optically by using light. This s …
  • Beijing Shouhang IHW Resources Saving Technology Co Ltd (002665):電力:M&Aディール及び事業提携情報
    Summary Beijing Shouhang IHW Resources Saving Technology Co Ltd (Shouhang IHW Resources) is an electrical equipment company that offers heat generation systems. The company designs, manufactures and distributes CSP power generating system, thermal power plant air cooling system, waste heat power gen …
  • Roper Technologies Inc (ROP):企業の財務・戦略的SWOT分析
    Roper Technologies Inc (ROP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Northwest Biotherapeutics Inc (NWBO):企業の財務・戦略的SWOT分析
    Northwest Biotherapeutics Inc (NWBO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Foodwell Corporation:企業の戦略・SWOT・財務分析
    Foodwell Corporation - Strategy, SWOT and Corporate Finance Report Summary Foodwell Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆